4155: OK Biotech Co., Ltd. - Summary | Jitta

OK Biotech Co., Ltd.

TWN:4155

Price
NT$13.00
Loss Chance
47.9%
3.16JITTA SCORE
20.30%Over Jitta Line
Jitta Ranking
435 / 1,077
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (34)
Recent Business Performance (61)
Financial Strength (63)
Return to Shareholders (15)
Competitive Advantage (30)
Jitta Signs
Revenue and EarningRevenue decline from 2022-2025
Operating MarginInconsistent
Recent Business PerformanceEarning decline 14.35% in the last year
CapExVery High
SG&A to SalesIncreasing
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
3.16
20.30%
3.79
645.83%
Health Care Supplies
4.53
71.23%
6.62
44.93%
5.49
15.41%
COMPANY DESCRIPTION
OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-frequency therapy devices, and factory setup solutions, as well as professional OEM/ODM customized services. The company sells its products under the OKB and Prodigy brands. OK Biotech Co., Ltd. was incorporated in 2004 and is headquartered in Hsinchu City, Taiwan.